TRADING UPDATES: OptiBiotix Health hails 2025 revenue surge
1st Apr 2026 14:29
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 9.00p on 16-04-2026 at 18:50:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 9.30p |
| Sell | 8.70p |
| Last Trade: | Buy 418.00 at 9.30p |
| Day's Volume: | 109,044 |
| Last Close: | 9.00p |
| Open: | 9.00p |
| ISIN: | GB00BGKPX309 |
| Day's Range | 9.00p - 9.00p |
| 52wk Range: | 8.35p - 14.30p |
| Market Capitalisation: | £30.22m |
| VWAP: | 8.945084p |
| Shares in Issue: | 335.73m |
Sector: Brokerage Services
Listed In: FTSE AIM All-Share,
Cavendish Plc (CAV) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 418 | 9.30p | Ordinary |
15:20:19 - 16-Apr-26 |
| Buy* | 412 | 9.30p | SI Trade |
15:20:19 - 16-Apr-26 |
| Sell* | 228 | 8.76p | Ordinary |
15:07:00 - 16-Apr-26 |
| Sell* | 358 | 8.76p | Ordinary |
15:06:53 - 16-Apr-26 |
| Sell* | 17,500 | 8.95p | Ordinary |
14:18:11 - 16-Apr-26 |
| Sell* | 25,000 | 8.95p | Ordinary |
10:48:02 - 16-Apr-26 |
| Sell* | 8,379 | 8.95p | Ordinary |
10:11:58 - 16-Apr-26 |
| Sell* | 55,928 | 8.94p | Ordinary |
10:07:49 - 16-Apr-26 |
| Sell* | 821 | 8.76p | Ordinary |
09:31:06 - 16-Apr-26 |
| Sell* | 4,556 | 8.75p | Ordinary |
16:17:07 - 15-Apr-26 |
Cavendish Plc (CAV) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Apr 2026 3:18 pm | RNS | Directors Dealings |
| 1st Apr 2026 7:00 am | RNS | Full Year Trading Update |
| 26th Feb 2026 3:38 pm | RNS | Holding(s) in Company |
| 3rd Feb 2026 2:30 pm | RNS | Directors Dealings |
| 18th Dec 2025 9:08 am | RNS | Directors Dealings |
| 15th Dec 2025 4:15 pm | RNS | Director Dealing: Correction |
| 11th Dec 2025 4:00 pm | RNS | Director Dealing |
| 2nd Dec 2025 7:00 am | RNS | Block Admission Return and Total Voting Rights |
| 21st Nov 2025 4:45 pm | RNS | Holding(s) in Company |
| 30th Oct 2025 7:00 am | RNS | 2026 Interim Results |